Failure to suppress markers of bone turnover on first-line hormone therapy for metastatic prostate cancer is associated with shorter time to skeletal-related event

Hahn, N.; Yiannoutsos, C.; Kirkpatrick, K.; Sharma, J.; Sweeney, C.

doi:10.1016/j.clgc.2013.07.002

Failure to suppress markers of bone turnover on first-line hormone therapy for metastatic prostate cancer is associated with shorter time to skeletal-related event

Date

2014

Authors

Hahn, N.

Yiannoutsos, C.

Kirkpatrick, K.

Sharma, J.

Sweeney, C.

Type:

Journal article

Citation

Clinical Genitourinary Cancer, 2014; 12(1):33-40.e4

Statement of Responsibility

Noah M. Hahn, Constantin T. Yiannoutsos, Kristina Kirkpatrick, Jaya Sharma, Christopher J. Sweeney

DOI

10.1016/j.clgc.2013.07.002

Abstract

Abstract not available

Rights

Published Version

https://doi.org/10.1016/j.clgc.2013.07.002

Persistent link to this record

http://hdl.handle.net/2440/91763

Full item page

Failure to suppress markers of bone turnover on first-line hormone therapy for metastatic prostate cancer is associated with shorter time to skeletal-related event

Date

Authors

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Citation

Statement of Responsibility

Conference Name

DOI

Abstract

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

License

Grant ID

Published Version

Call number

Persistent link to this record